CONFORM Clinical Trial
The CONFORM Pivotal Trial is evaluating the CLAAS® System compared to other commercially available LAAO devices in patients with non-valvular Afib.

The CONFORM Pivotal Trial is evaluating the CLAAS® System compared to other commercially available LAAO devices in patients with non-valvular Afib.
CAUTION: Investigational device. Limited by Federal (or United States) law to investigational use. Not for sale in any geography.
Please contact your physician or enrolling site coordinator for a full list of eligibility criteria. Prior to participating, the clinical staff will review the study risks and benefits and address your questions as part of the informed consent process. As part of the trial, you’ll have several responsibilities.
Like to learn more? Find a clinical site near you.
Ventura, CAL Fire Southern Region, California
New Haven,
Norfolk, VA
Providence, RI
Tucson, AZ
Columbus, OH
Columbus, OH
Kansas City, MO
Kendall, FL
Tampa, FL
New York, NY
Detroit, MI
Tupelo, MS
Morristown, NJ
Asheville, NC
Atlanta, GA
Scottsdale, AZ
Burlington, MA
Katy, TX
Roanoke, VA
New York, NY
Knoxville, TN
Wichita, KS
Jacksonville, FL
Cincinnati, OH
Chattanooga, TN
Atlanta, GA
Manchester, NH
Nashville-Davidson, TN
Birmingham, AL
Jonesboro, AR
Santa Monica, CA
Wynnewood, PA